FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy

Retrieved on: 2025-07-25 23:28:31

Tags for this article:

Click the tags to see associated articles and topics

FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration said on Friday it was investigating the death of an eight-year-old boy who received Sarepta Therapeutics' ...

Article found on: www.tradingview.com